Ignite Creation Date:
2024-05-05 @ 11:38 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00098995
Status:
COMPLETED
Last Update Posted:
2013-06-26
First Post:
2004-12-08
Brief Title:
Tirapazamine Cisplatin and Radiation Therapy in Treating Patients With Stage IB Stage II Stage III or Stage IVA Cervical Cancer
Sponsor:
Peter MacCallum Cancer Centre Australia
Organization:
National Cancer Institute NCI
Organization Data
Organization:
National Cancer Institute NCI
Class:
NIH
Study ID:
PMCC-2004354
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Peter MacCallum Cancer Centre Australia
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |